Follow The Filings

QCRH QCR

QCR earnings company data as of 4:47 AM ET 10/2

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 28 Oct EPS 2.09 — —
Rev — — —

Insider trades

Open-market buys and sales by QCRH's executives, directors and 10% owners in the last 12 months, from their Form 4s

All QCRH insider trades
  • $14K bought by 1 insider
  • $918K sold by 3 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Amy L Reasner Director
    Buy
    $5,415 60 shares at $90.25 +4.3% to stake
    Traded Jun 2 Filed Jun 10
  2. Laura L Ekizian President & CEO, QCBT
    Sale
    $71K 750 shares at $94.96 11% of stake
    Traded Jun 9 Filed Jun 10
  3. James D. Klein President, CRBT
    Sale
    $26K 428 shares at $60.74 58% of stake
    Traded May 12, 2025 Filed Jun 8
  4. James D. Klein President, CRBT
    Sale
    $28K 310 shares at $91.00 42% of stake
    Traded Apr 30 Filed Apr 30
  5. Amy L Reasner Director
    Buy
    $8,835 100 shares at $88.35 +7.6% to stake
    Traded Apr 23 Filed Apr 24
  6. James D. Klein President, CRBT
    Sale
    $46K 554 shares at $82.50 43% of stake
    Traded Mar 12 Filed Mar 12
  7. Todd A Gipple CFO
    Sale
    $772K 8,590 shares at $89.92 16% of stake
    Traded Jan 30 Filed Feb 2

Also filed in the last 12 months, not counted as buying or selling: 30 option exercises and 10 stock grants.

SEC filings

Recent issuer filings from EDGAR, 14 shown.

Filed Form Detail Links
8-K 7.01,9.01
8-K 2.02,9.01
8-K 8.01,9.01
10-Q
8-K 7.01,9.01
8-K 2.02,9.01
8-K 5.07,8.01,9.01
10-Q
SCHEDULE 13G/A —
8-K 2.02,9.01
8-K 7.01,9.01
DEF 14A FORM DEF 14A
DEFA14A
SCHEDULE 13G/A —

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.